Orthofix Medical Inc. OFIX
7.05 USD -0.13 (-1.81%)
Nov 12, 2026, 12:43 PM EST
7.02 Day range 7.31
6.52 52-week range 16.42
- YTD
- -53.50%
- 1 year
- -53.92%
Benzinga news
benzinga.com 12 Health Care Stocks Moving In Wednesday's After-Market Session Gainers Can Fite Biopharma (AMEX:CANF) stock rose 7.1% to $1.66 during Wednesday's after-market session. The market value of their outstanding shares is at $3.5 million. iTonic Holdings (NASDAQ:ITOC)…
benzinga.com Orthofix Medical Q3 2026 Earnings Call Transcript Orthofix Medical (NASDAQ:OFIX) reported third-quarter financial results on Monday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to…
benzinga.com Orthofix Medical Lowers FY2026 Sales Guidance from $845.000M-$855.000M to $825.000M-$830.000M vs $851.203M Est Orthofix Medical (NASDAQ:OFIX) lowers FY2026 sales outlook from $845.000 million-$855.000 million to $825.000 million-$830.000 million vs $851.203 million estimate.
benzinga.com Canaccord Genuity Maintains Buy on Orthofix Medical, Lowers Price Target to $13 Canaccord Genuity analyst Caitlin Burrows maintains Orthofix Medical (NASDAQ:OFIX) with a Buy and lowers the price target from $18 to $13.- benzinga.com 12 Health Care Stocks Moving In Wednesday's After-Market Session Gainers Creative Medical Tech (NASDAQ:CELZ) stock moved upwards by 31.4% to $0.88 during Wednesday's after-market session. The company's market cap stands at $4.2 million. Caris Life Sciences…
benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session Gainers Bluejay Diagnostics (NASDAQ:BJDX) shares moved upwards by 43.0% to $1.43 during Wednesday's pre-market session. The company's market cap stands at $1.0 million. Estrella Immunopharma…- benzinga.com Orthofix Medical Raises FY2026 Sales Guidance from $838.000M-$848.000M to $845.000M-$855.000M vs $843.311M Est Orthofix Medical (NASDAQ:OFIX) raises FY2026 sales outlook from $838.000 million-$848.000 million to $845.000 million-$855.000 million vs $843.311 million estimate.
benzinga.com Orthofix Medical Q2 Adj. EPS $0.07 Beats $(0.41) Estimate, Sales $210.933M Beat $209.277M Estimate Orthofix Medical (NASDAQ:OFIX) reported quarterly earnings of $0.07 per share which beat the analyst consensus estimate of $(0.41) by 117.07 percent. This is a 46.15 percent decrease over earnings of…
benzinga.com These 7 Small Caps Are on Fire as the Second Half Begins: Here’s Why Seven small-cap stocks have surged as much as 123% in early July on buyouts, FDA developments, refinancing deals and short squeezes.
benzinga.com Reported July 2, 2026: Orthofix Medical Says Medicare Will Restore Pre-May 18 Reimbursement Rates For Bone Growth Stimulators After CMS Reversal On April 16, 2026, the U.S. Food and Drug Administration ("FDA") issued a final order reclassifying non-invasive bone growth stimulators from Class III to Class II devices. Following that order, the…
benzinga.com Terawulf, Ceva, Western Digital And Other Big Stocks Moving Higher On Monday Stocks mixed, Dow falls 100 points. Terawulf Inc (NASDAQ: WULF) rises after lease deal. Other big gainers: OFIX, AXTI, SHAZ, IREN, CEVA, IMOS, CRDO, HUT, BFLY, CHRN, BE, ALAB, SIMO.
benzinga.com 12 Health Care Stocks Moving In Thursday's After-Market Session Gainers Seer (NASDAQ:SEER) stock moved upwards by 33.3% to $2.16 during Thursday's after-market session. The market value of their outstanding shares is at $89.6 million. Universe Pharmaceuticals…
benzinga.com Alpha Buying: Wall Street Gave Up. Management Didn't. 
benzinga.com Canaccord Genuity Maintains Buy on Orthofix Medical, Lowers Price Target to $18 Canaccord Genuity analyst Caitlin Burrows maintains Orthofix Medical (NASDAQ:OFIX) with a Buy and lowers the price target from $20 to $18.
benzinga.com Chevron To Rally Around 12%? Here Are 10 Top Analyst Forecasts For Friday Get the latest analyst rating changes for top companies on Wall Street, including upgrades and downgrades. View complete details at Benzinga.
benzinga.com Barrington Research Maintains Outperform on Orthofix Medical, Lowers Price Target to $15 Barrington Research analyst Michael Petusky maintains Orthofix Medical (NASDAQ:OFIX) with a Outperform and lowers the price target from $17 to $15.
benzinga.com Stifel Maintains Buy on Orthofix Medical, Lowers Price Target to $15 Stifel analyst Thomas Stephan maintains Orthofix Medical (NASDAQ:OFIX) with a Buy and lowers the price target from $18 to $15.- benzinga.com Orthofix Medical Announces New Pediatric Limb Reconstruction Innovations That Expand Treatment Options For Pediatric And Small Stature Patients The Company will highlight these advances at the Pediatric Orthopedic Society of North America (POSNA) 2026 Annual Meeting, which takes place May 6-8, 2026, at the Rosen Shingle Creek Hotel in…
- benzinga.com Full Transcript: Orthofix Medical Q1 2026 Earnings Call
- benzinga.com Orthofix Medical Affirms FY2026 Sales Guidance of $850.000M-$860.000M vs $855.606M Est Orthofix Medical (NASDAQ:OFIX) affirms FY2026 sales outlook from $850.000 million-$860.000 million to $850.000 million-$860.000 million vs $855.606 million estimate.
- benzinga.com Orthofix Medical Q1 Adj. EPS $(0.13) Beats $(0.68) Estimate, Sales $196.700M Beat $193.985M Estimate Orthofix Medical (NASDAQ:OFIX) reported quarterly losses of $(0.13) per share which beat the analyst consensus estimate of $(0.68) by 80.88 percent. This is a 62.5 percent decrease over losses of…
benzinga.com Earnings Scheduled For May 5, 2026 
benzinga.com Orthofix Reaffirms FY26 Net Sales Outlook Of $850M-$860M; Reports Preliminary Q1 Net Sales Of ~$196.7M, And Non-GAAP Pro Forma Net Sales Of ~$196.4M Company Reports Preliminary First Quarter 2026 Net Sales and Reaffirms 2026 OutlookOrthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced a strategic…
benzinga.com A Glimpse Into The Expert Outlook On Orthofix Medical Through 5 Analysts - benzinga.com Stifel Maintains Buy on Orthofix Medical, Lowers Price Target to $18 Stifel analyst Thomas Stephan maintains Orthofix Medical (NASDAQ:OFIX) with a Buy and lowers the price target from $22 to $18.
- benzinga.com Canaccord Genuity Maintains Buy on Orthofix Medical, Lowers Price Target to $20 Canaccord Genuity analyst Caitlin Burrows maintains Orthofix Medical (NASDAQ:OFIX) with a Buy and lowers the price target from $24 to $20.
benzinga.com Orthofix Medical Earnings Review: Q4 Summary - benzinga.com Orthofix Medical Sees FY2026 Sales $850.000M-$860.000M vs $862.758M Est Orthofix Medical (NASDAQ:OFIX) sees FY2026 sales of $850.000 million-$860.000 million vs $862.758 million analyst estimate.
- benzinga.com Orthofix Medical Q4 Adj. EPS $0.24 Beats $0.12 Estimate, Sales $219.911M Beat $218.861M Estimate. Orthofix Medical (NASDAQ:OFIX) reported quarterly earnings of $0.24 per share which beat the analyst consensus estimate of $0.12 by 100 percent. This is a 1100 percent increase over earnings of $0.02…
- benzinga.com Earnings Scheduled For February 24, 2026
benzinga.com Earnings Outlook For Orthofix Medical - benzinga.com Barrington Research Maintains Outperform on Orthofix Medical, Maintains $18 Price Target Barrington Research analyst Michael Petusky maintains Orthofix Medical (NASDAQ:OFIX) with a Outperform and maintains $18 price target.
- benzinga.com TD Cowen Initiates Coverage On Orthofix Medical with Hold Rating, Announces Price Target of $14 TD Cowen analyst Mathew Blackman initiates coverage on Orthofix Medical (NASDAQ:OFIX) with a Hold rating and announces Price Target of $14.
- benzinga.com Barrington Research Maintains Outperform on Orthofix Medical, Raises Price Target to $18 Barrington Research analyst Michael Petusky maintains Orthofix Medical (NASDAQ:OFIX) with a Outperform and raises the price target from $17 to $18.
- benzinga.com Orthofix Medical Narrows FY2025 Sales Guidance from $808.000M-$816.000M to $810.000M-$814.000M vs $813.559M Est Orthofix Medical (NASDAQ:OFIX) narrows FY2025 sales outlook from $808.000 million-$816.000 million to $810.000 million-$814.000 million vs $813.559 million estimate.
- benzinga.com Orthofix Medical Q3 Adj. EPS $0.20, Sales $205.600M Beat $200.006M Estimate Orthofix Medical (NASDAQ:OFIX) reported quarterly earnings of $0.20 per share which beat the analyst consensus estimate of $(0.41) by 149.14 percent. This is a 185.71 percent increase over earnings…
benzinga.com Earnings Scheduled For November 4, 2025 
benzinga.com Carlsmed's Personalized Spine Implants Get Significant Reimbursement Advantage Carlsmed secures NTAP reimbursement and FDA support, while BofA projects strong revenue growth and assigns a Buy rating with a $16 target.- benzinga.com Earnings Scheduled For August 5, 2025
- benzinga.com Earnings Scheduled For May 6, 2025
- benzinga.com Earnings Scheduled For February 25, 2025
benzinga.com Why Meta Platforms Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket 
benzinga.com Why Versus Systems Shares Are Trading Higher By Around 71%; Here Are 20 Stocks Moving Premarket - benzinga.com Earnings Scheduled For March 5, 2024 Companies Reporting Before The Bell • NIO (NYSE:NIO) is estimated to report quarterly loss at $0.51 per share on revenue of $2.29 billion.
- benzinga.com Acuity Brands Posts Upbeat Earnings, Joins Accolade, Urban Outfitters And Other Big Stocks Moving Higher On Tuesday U.S. stocks traded lower, with the Dow Jones index falling over 250 points on Tuesday.
- benzinga.com Earnings Scheduled For November 8, 2023 Companies Reporting Before The Bell • Flex LNG (NYSE:FLNG) is estimated to report earnings for its third quarter.
- benzinga.com Benzinga's Top Ratings Upgrades, Downgrades For October 20, 2023
- benzinga.com Stocks That Hit 52-Week Lows On Tuesday Tuesday saw 132 companies set new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Thursday On Thursday, 369 companies hit new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Thursday During the session on Thursday, 461 stocks hit new 52-week lows.